DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)

China flag China · Delayed Price · Currency is CNY
19.90
+0.32 (1.63%)
Jan 22, 2026, 3:00 PM CST
44.52%
Market Cap22.66B
Revenue (ttm)26.83B
Net Income (ttm)1.14B
Shares Out1.14B
EPS (ttm)1.01
PE Ratio19.67
Forward PE18.09
Dividend0.68 (3.47%)
Ex-Dividend DateNov 6, 2025
Volume4,663,298
Average Volume6,391,797
Open19.59
Previous Close19.58
Day's Range19.45 - 20.04
52-Week Range13.50 - 19.99
Beta0.65
RSI70.86
Earnings DateApr 24, 2026

About SHA:603233

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 43,532
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603233
Full Company Profile

Financial Performance

In 2024, SHA:603233's revenue was 26.50 billion, an increase of 8.01% compared to the previous year's 24.53 billion. Earnings were 914.75 million, a decrease of -21.58%.

Financial Statements